menu
    • menu

    Find Mifepristone manufacturers, exporters & distributors on PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Gonane Mifepristone

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    18

    API Suppliers

    API Suppliers

    6

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    1

    JDMF

    JDMFs Filed

    3

    EU WC

    EU WC

    0

    KDMF

    KDMF

    9

    NDC API

    NDC API

    0

    VMF

    NDC API

    14

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 836

    MARKET PLACE

    12

    API

    1

    FDF

    5INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    30

    FDF Dossiers

    FDF Dossiers

    4

    FDA Orange Book

    FDA (Orange Book)

    9

    Europe

    Europe

    1

    Canada

    Canada

    1

    Australia

    Australia

    2

    South Africa

    South Africa

    13

    Listed Dossiers

    Listed Dossiers

    6DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    1

    USP

    0

    JP

    1

    Others

    PATENTS & EXCLUSIVITIES

    18

    US Patents

    1

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    3

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    62

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    187,312,598

    Annual Reports

    NA

    Finished Drug Prices

    Listed Dossiers

    141 RELATED EXCIPIENT COMPANIES

    240EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 84371-65-3, Mifegyne, Mifeprex, Ru-486, Korlym, Ru486
    Molecular Formula
    C29H35NO2
    Molecular Weight
    429.6  g/mol
    InChI Key
    VKHAHZOOUSRJNA-GCNJZUOMSA-N
    FDA UNII
    320T6RNW1F
    Mifepristone
    A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.
    Mifepristone is a Progestin Antagonist. The mechanism of action of mifepristone is as a Progestational Hormone Receptor Antagonist.
    1 2D Structure

    Mifepristone

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
    2.1.2 InChI
    InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1
    2.1.3 InChI Key
    VKHAHZOOUSRJNA-GCNJZUOMSA-N
    2.1.4 Canonical SMILES
    CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O
    2.1.5 Isomeric SMILES
    CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O
    2.2 Other Identifiers
    2.2.1 UNII
    320T6RNW1F
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Mifgyne

    2. Mifegyne

    3. Mifeprex

    4. R 38486

    5. R-38486

    6. R38486

    7. Ru 38486

    8. Ru 486

    9. Ru-38486

    10. Ru-486

    11. Ru38486

    12. Ru486

    13. Zk 98296

    14. Zk-98296

    15. Zk98296

    2.3.2 Depositor-Supplied Synonyms

    1. 84371-65-3

    2. Mifegyne

    3. Mifeprex

    4. Ru-486

    5. Korlym

    6. Ru486

    7. Ru 486

    8. Mifepriston

    9. Corlux

    10. Ru 38486

    11. Ru-38486

    12. Mls000069785

    13. 320t6rnw1f

    14. Vgx-410c

    15. Chebi:50692

    16. Vgx-410

    17. Nsc-759862

    18. Ncgc00025179-05

    19. Smr000058481

    20. Mifepristonum [latin]

    21. Mifepristona [spanish]

    22. Dsstox_cid_3322

    23. C-1073

    24. Dsstox_rid_76976

    25. Dsstox_gsid_23322

    26. (11beta,17beta)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propyn-1-yl)estra-4,9-dien-3-one

    27. (8s,11r,13s,14s,17s)-11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(prop-1-yn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-3-one

    28. (8s,11r,13s,14s,17s)-11-(4-dimethylaminophenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one

    29. (8s,11r,13s,14s,17s)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one

    30. 11-(4-dimethylamino-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec Ahydro-cyclopenta[a]phenanthren-3-one

    31. Mifepristona

    32. Mifepristonum

    33. (11beta,17beta)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-prop-1-yn-1-ylestra-4,9-dien-3-one

    34. Ru486 (tetramethyl-rhodamine Conjugated)

    35. Mifepristone [usan:inn:ban]

    36. Hsdb 6841

    37. Sr-01000076011

    38. R 38486

    39. Brn 5779404

    40. Unii-320t6rnw1f

    41. Pictovir

    42. Ru 486-6

    43. Ccris 9332

    44. 1nhz

    45. 11beta-(p-(dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one

    46. Mifeprex (tn)

    47. Pictovir (tm)

    48. Prestwick_570

    49. Cas-84371-65-3

    50. Korlym (tn)

    51. 2w8y

    52. Mifepristone (mifeprex)

    53. Opera_id_562

    54. Mifepristone, >=98%

    55. Prestwick0_000299

    56. Prestwick1_000299

    57. Prestwick2_000299

    58. Prestwick3_000299

    59. Spectrum5_002045

    60. Mifepristone [mi]

    61. Mifepristone [inn]

    62. Mifepristone [jan]

    63. Mifepristone [hsdb]

    64. Mifepristone [usan]

    65. 11beta-(4-(dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-on

    66. 17-beta-hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oestra-4,9-dien-3-one

    67. Mifepristone [vandf]

    68. Bidd:pxr0123

    69. Lopac0_000801

    70. Schembl16087

    71. Bspbio_000238

    72. Mifepristone [mart.]

    73. 11beta-(4-(dimethylamino)phenyl)-17-hydroxy-21-methyl-19-nor-17alpha-pregna-4,9-dien-20-m-3-on

    74. 11beta-(4-(n,n-dimethylamino)phenyl)-17alpha-(prop-1-ynyl)-delta4,9-estradiene-17beta-ol-3-one

    75. Mls001074115

    76. Mls001424271

    77. (non-labelled)mifepristone-d3

    78. Mifepristone [usp-rs]

    79. Mifepristone [who-dd]

    80. Spbio_002457

    81. Ru-486; Mifepristone

    82. Bpbio1_000262

    83. Chembl438575

    84. Gtpl2805

    85. Mifepristone (jan/usan/inn)

    86. Chembl1276308

    87. Dtxsid5023322

    88. Bdbm18627

    89. Hms1568l20

    90. Hms2052l05

    91. Hms2090l22

    92. Hms2095l20

    93. Hms2230p21

    94. Hms3262b03

    95. Hms3412d17

    96. Hms3649j08

    97. Hms3676d17

    98. Hms3712l20

    99. Hms3884d12

    100. Mifepristone [orange Book]

    101. 11.beta.-(p-(dimethylamino)phenyl)-17.beta.-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one

    102. Act02598

    103. Bcp02145

    104. Zinc3831128

    105. Tox21_110952

    106. Tox21_301841

    107. Tox21_500801

    108. Bdbm50072024

    109. Hsci1_000369

    110. S2606

    111. Vx-410

    112. Akos015895416

    113. Tox21_110952_1

    114. Ccg-101164

    115. Ci-1073

    116. Cs-1435

    117. Db00834

    118. Lp00801

    119. Nc00414

    120. Nsc 759862

    121. Sdccgsbi-0050778.p002

    122. Mifepristone 1.0 Mg/ml In Acetonitrile

    123. Ncgc00025179-06

    124. Ncgc00025179-07

    125. Ncgc00025179-08

    126. Ncgc00025179-09

    127. Ncgc00025179-12

    128. Ncgc00025179-13

    129. Ncgc00025179-23

    130. Ncgc00179632-01

    131. Ncgc00255152-01

    132. Ncgc00261486-01

    133. (11beta,17beta)-11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one

    134. As-13938

    135. Cpd000058481

    136. Estra-4,9-dien-3-one, 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-, (11-beta,17-beta)-

    137. Hy-13683

    138. Ru486;c-1073

    139. Eu-0100801

    140. C07652

    141. D00585

    142. M 8046

    143. 371m653

    144. A840767

    145. Q411240

    146. Sr-01000721888

    147. Q-201405

    148. Sr-01000076011-1

    149. Sr-01000076011-3

    150. Sr-01000076011-5

    151. Sr-01000076011-9

    152. Sr-01000721888-4

    153. Brd-k37270826-001-04-5

    154. Brd-k37270826-001-31-8

    155. Mifepristone, United States Pharmacopeia (usp) Reference Standard

    156. (11?,17?)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one

    157. 11.beta.-[4-(dimethylamino)phenyl]-17.beta.-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one

    158. 11beta-(4-dimethylamino)phenyl-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one

    159. 11ss-[p-(dimethylamino)fenyl]-17ss-hydroxy- 17-(1-propynyl)estra-4,9-dien-3-on

    160. (10s,11s,14s,15s,17r)-17-[4-(dimethylamino)phenyl]-14-hydroxy-15-methyl-14-(prop-1-yn-1-yl)tetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-1,6-dien-5-one

    161. (10s,11s,14s,15s,17r)-17-[4-(dimethylamino)phenyl]-14-hydroxy-15-methyl-14-(prop-1-yn-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6-dien-5-one

    162. (11.beta.,17.beta.)-11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one

    163. (11r,13s,14s,17s)-11-(4-dimethylamino-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-cyclopenta[a]phenanthren-3-one

    164. (8s,11r,13s,14s,17s)-11-[4-(dimethylamino)phenyl]-13-methyl-17-oxidanyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one

    165. 122742-25-0

    166. 83203-42-3

    167. Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propyn-1-yl)-, (11.beta.,17.beta.)-

    168. Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)-, (11b,17b)-

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 429.6 g/mol
    Molecular Formula C29H35NO2
    XLogP33.8
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count3
    Exact Mass429.266779359 g/mol
    Monoisotopic Mass429.266779359 g/mol
    Topological Polar Surface Area40.5 Ų
    Heavy Atom Count32
    Formal Charge0
    Complexity921
    Isotope Atom Count0
    Defined Atom Stereocenter Count5
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameKorlym
    PubMed HealthMifepristone (By mouth)
    Drug ClassesAntiglucocorticoid, Antiprogesterone
    Drug LabelKorlym (mifepristone) is a cortisol receptor blocker for oral administration. The chemical name of mifepristone is 11-(4-dimethylaminophenyl)-17-hydroxy-17-(1-propynyl)-estra-4, 9-dien-3-one. The chemical formula is C29H35NO2; the molecular wei...
    Active IngredientMifepristone
    Dosage FormTablet
    RouteOral
    Strength300mg
    Market StatusPrescription
    CompanyCorcept Therap

    2 of 4  
    Drug NameMifeprex
    Active IngredientMifepristone
    Dosage FormTablet
    RouteOral
    Strength200mg
    Market StatusPrescription
    CompanyDanco Labs

    3 of 4  
    Drug NameKorlym
    PubMed HealthMifepristone (By mouth)
    Drug ClassesAntiglucocorticoid, Antiprogesterone
    Drug LabelKorlym (mifepristone) is a cortisol receptor blocker for oral administration. The chemical name of mifepristone is 11-(4-dimethylaminophenyl)-17-hydroxy-17-(1-propynyl)-estra-4, 9-dien-3-one. The chemical formula is C29H35NO2; the molecular wei...
    Active IngredientMifepristone
    Dosage FormTablet
    RouteOral
    Strength300mg
    Market StatusPrescription
    CompanyCorcept Therap

    4 of 4  
    Drug NameMifeprex
    Active IngredientMifepristone
    Dosage FormTablet
    RouteOral
    Strength200mg
    Market StatusPrescription
    CompanyDanco Labs

    4.2 Therapeutic Uses

    Abortifacient Agents, Steroidal; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Hormone Antagonists; Luteolytic Agents; Menstruation-Inducing Agents

    National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)

    Mifepristone is indicated in combination with misoprostol for the medical termination of intrauterine pregnancy of 49 days duration or less. /Included in US product labeling/

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1971

    4.3 Drug Warning

    Confirmed or suspected ectopic pregnancy, undiagnosed adnexal mass, or IUD currently in place. Chronic adrenal failure or concurrent long-term corticosteroid therapy. Known hypersensitivity to mifepristone, misoprostol, or other prostaglandins. Hemorrhagic disorders, inherited porphyrias, or concurrent anticoagulant therapy.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 3148

    Vaginal bleeding that is heavier than associated with a normal menses occurs in almost all women receiving mifepristone and misoprostol. Based on clinical studies, bleeding or spotting should be expected for an average of 9-16 days. ... Excessive bleeding may require treatment with vasoconstrictors, saline infusions, and/or blood transfusions or curettage.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 3148

    Severe vaginal bleeding may occur following spontaneous, surgical, or medical abortion (including following mifepristone administration). Prolonged heavy vaginal bleeding (i.e. soaking through 2 thick full-size sanitary pads per hour for 2 consecutive hours) may be a sign of incomplete abortion or other complications, and prompt medical or surgical intervention maybe required to prevent the development of hypovolemic shock. Patients should be advised to seek immediate medical attention if prolonged heavy vaginal bleeding or syncope occurs following mifepristone administration.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 3148

    Serious bacterial infections (including very rare cases of fatal septic shock) have been reported following mifepristone administration; a causal relationship to the mifepristone-misoprostol regimen has not been established. Clinicians should consider the possibility of infection if sustained fever (temperature of 38 degrees C or higher persisting for more than 4 hours), severe abdominal pain, or pelvic tenderness occurs within several days of medical abortion. Atypical presentations of serious infection and sepsis (i.e., presence of significant leukocytosis, tachycardia, or hemoconcentration without fever, severe abdominal pain, pelvic tenderness) may also occur.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 3148

    For more Drug Warnings (Complete) data for MIFEPRISTONE (14 total), please visit the HSDB record page.

    4.4 Drug Indication

    For the medical termination of intrauterine pregnancy through 49 days' pregnancy. Also indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and are not candidates for surgery or have had unsuccessful surgery.

    FDA Label

    Treatment of endometriosis

    Treatment of hypercortisolism (Cushing's syndrome) of endogenous origin

    Treatment of leiomyoma of uterus

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Mifepristone is a synthetic steroid with antiprogestational effects indicated for the medical termination of intrauterine pregnancy through 49 days' pregnancy. Doses of 1 mg/kg or greater of mifepristone have been shown to antagonize the endometrial and myometrial effects of progesterone in women. During pregnancy, the compound sensitizes the myometrium to the contraction-inducing activity of prostaglandins. Mifepristone also exhibits antiglucocorticoid and weak antiandrogenic activity. The activity of the glucocorticoid dexamethasone in rats was inhibited following doses of 10 to 25 mg/kg of mifepristone. Doses of 4.5 mg/kg or greater in human beings resulted in a compensatory elevation of adrenocorticotropic hormone (ACTH) and cortisol.

    5.2 MeSH Pharmacological Classification

    Contraceptives, Oral, Synthetic

    Oral contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Oral, Synthetic.)

    Luteolytic Agents

    Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM. (See all compounds classified as Luteolytic Agents.)

    Contraceptives, Postcoital, Synthetic

    Postcoital contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Postcoital, Synthetic.)

    Abortifacient Agents, Steroidal

    Steroidal compounds with abortifacient activity. (See all compounds classified as Abortifacient Agents, Steroidal.)

    Menstruation-Inducing Agents

    Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. (From Dorland, 27th ed) (See all compounds classified as Menstruation-Inducing Agents.)

    Hormone Antagonists

    Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    MIFEPRISTONE
    5.3.2 FDA UNII
    320T6RNW1F
    5.3.3 Pharmacological Classes
    Progestin Antagonist [EPC]; Progestational Hormone Receptor Antagonists [MoA]
    5.4 ATC Code

    G03XB01

    S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

    G - Genito urinary system and sex hormones

    G03 - Sex hormones and modulators of the genital system

    G03X - Other sex hormones and modulators of the genital system

    G03XB - Progesterone receptor modulators

    G03XB01 - Mifepristone

    5.5 Absorption, Distribution and Excretion

    Absorption

    The absolute bioavailability of a 20 mg oral dose is 69%

    Route of Elimination

    Fecal: 83%; Renal: 9%.

    The absolute bioavailability of oral mifepristone is 69%.

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1971

    Protein binding: Very high (98%); predominantly to albumin and alpha1- acid glycoprotein.

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1971

    Time to peak concentration: 90 minutes after a 600 mg oral dose.

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1971

    Peak plasma concentration: 1.98 mg/L following a single 600 mg oral dose.

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1971

    Fecal; 83% of a 600 mg dose over 11 days. Renal; 9% of a 600 mg dose over 11 days.

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1971

    5.6 Metabolism/Metabolites

    Hepatic. Hepatic, by Cytochrome P450 3A4 isoenzyme to the N-monodemethylated metabolite (RU 42 633); RU 42 698, which results from the loss of two methyl groups from position 11 beta; and RU 42 698, which results from terminal hydroxylation of the 17–propynyl chain.

    Hepatic, by Cytochrome P450 3A4 isoenzyme to the N-monodemethylated metabolite (RU 42 633); RU 42 698, which results from terminal hydroxylation of the 17-propynyl chain.

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1971

    Mifepristone has known human metabolites that include 17alpha-hydroxymifepristone and Monodemethylated mifepristone.

    S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560

    5.7 Biological Half-Life

    18 hours

    Terminal: 18 hours; begins slowly and becomes more rapid with time.

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1971

    5.8 Mechanism of Action

    The anti-progestational activity of mifepristone results from competitive interaction with progesterone at progesterone-receptor sites. Based on studies with various oral doses in several animal species (mouse, rat, rabbit and monkey), the compound inhibits the activity of endogenous or exogenous progesterone. The termination of pregnancy results. In the treatment of Cushing's syndrome, Mifepristone blocks the binding of cortisol to its receptor. It does not decrease cortisol production but reduces the effects of excess cortisol, such as high blood sugar levels.

    Mifepristone competitively inhibits the actions of progesterone at progesterone-receptor sites, resulting in termination of pregnancy.The combination of mifepristone and misoprostol causes expulsion of the products of conception through decidual necrosis, myometrial contractions, and cervical softening.

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1971

    When administered in the early stages of pregnancy, mifepristone causes decidual breakdown by blockade of uterine progesterone receptors. This leads to detachment of the blastocyte, which decreases hCG production. This in turn causes a decrease in progesterone secretion from the corpus luteum, which further accentuates decidual breakdown. Decreased endogenous progesterone coupled with blockade of progesterone receptors in the uterus increases prostaglandin levels and sensitizes the myometrium to the contractile actions of prostaglandins.

    Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1622

    In addition, mifepristone promotes uterine contractions and softening of the cervix and sensitizes the myometrium to effects of prostaglandins (e.g., misoprostol) that stimulate uterine contraction and expulsion of the products of conception. In the absence of progesterone, mifepristone acts as a partial progestin agonist. At dosages higher than those used for termination of pregnancy, mifepristone also exhibits antiglucocorticoid activity. The drug also has been shown to have weak antiandrogenic activity.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 3148

    API SUPPLIERS

    read-more
    read-more

    01

    Gonane Pharma

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Booth #2.A34
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Gonane Pharma

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    LGM Pharma

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BMWS24
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Seqens

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BMWS24
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 10577-915

    Start Marketing Date : 2011-01-28

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Seqens Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Hubei Gedian Humanwell Pharmaceuti...

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHubei Gedian Humanwell focuses on R&D, production, & sales of fertility regulation drugs & steroidal APIs.

    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 51508-011

    Start Marketing Date : 2022-03-04

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Hubei Gedian Humanwell Pharmaceutical

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Curia

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BMWS24
    Not Confirmed
    arrow

    Curia

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BMWS24
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 37250

    Submission : 2022-06-28

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 302MF10146

    Registrant's Address : Parque Tecnologico-Parcela 105 Boecillo (Valladolid) Spain

    Initial Date of Registration : 2020-12-15

    Latest Date of Registration : --

     EU-WC NDC arrow-down
    ✖

    NDC Package Code : 65089-0043

    Start Marketing Date : 2000-09-28

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Qinhuangdao Zizhu Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BMWS24
    Not Confirmed
    arrow

    Qinhuangdao Zizhu Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BMWS24
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 24628

    Submission : 2011-01-30

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 44132-005

    Start Marketing Date : 2012-06-08

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Zhejiang Xianju Pharmaceutical Co....

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BMWS24
    Not Confirmed
    arrow

    Zhejiang Xianju Pharmaceutical Co....

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BMWS24
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-11-16

    Pay. Date : 2017-08-21

    DMF Number : 31873

    Submission : 2017-07-20

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 60722-3002

    Start Marketing Date : 2020-10-23

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Naari

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BMWS24
    Not Confirmed
    arrow

    Naari

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BMWS24
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 37121

    Submission : 2022-05-12

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-09-01

    Valid Till : 2024-11-05

    Written Confirmation Number : WC-0297

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Zhejiang Xianju Junye Pharmaceutic...

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BMWS24
    Not Confirmed
    arrow

    Zhejiang Xianju Junye Pharmaceutic...

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BMWS24
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21944

    Submission : 2008-09-08

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Indo Phyto Chemicals Private Ltd

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BMWS24
    Not Confirmed
    arrow

    Indo Phyto Chemicals Private Ltd

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BMWS24
    Not Confirmed
    USDMF CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2018-11-05

    Valid Till : 2021-11-04

    Written Confirmation Number : WC-297

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705516200,"product":"SAP CODE : 2020952 HARMLESS PHARMACEUTICAL BULK DRUG : MIFEPRISTONE","address":"ACME PLAZA, ANDHERI KURLA ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"MONTREAL, QC","customer":"M\/S.","customerCountry":"CANADA","quantity":"71.12","actualQuantity":"71.12","unit":"KGS","unitRateFc":"2500","totalValueFC":"176387.4","currency":"USD","unitRateINR":206128.47722159731,"date":"18-Jan-2024","totalValueINR":"14659857.3","totalValueInUsd":"176387.4","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"6843903","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"ACME PLAZA, ANDHERI KURLA ROAD,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720463400,"product":"HSN CODE : 29372900 SAP CODE : 2020952 HARMLESS PHARMACEUTICAL BULK DRUG MIFEPRISTONE PACK : KG","address":"ACME PLAZA, ANDHERI KURLA ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"MONTREAL, QC","customer":"M\/S","customerCountry":"CANADA","quantity":"32.65","actualQuantity":"32.65","unit":"KGS","unitRateFc":"2500","totalValueFC":"80274.3","currency":"USD","unitRateINR":205519.63399693722,"date":"09-Jul-2024","totalValueINR":"6710216.05","totalValueInUsd":"80274.3","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"2282886","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"ACME PLAZA, ANDHERI KURLA ROAD,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698431400,"product":"MIFEPRISTONE IP","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"ZHEJIANG XIANJU PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"AQUATIC REMEDIES PVT LTD","customerCountry":"INDIA","quantity":"400.00","actualQuantity":"400","unit":"KGS","unitRateFc":"850","totalValueFC":"343965.4","currency":"USD","unitRateINR":"71570","date":"28-Oct-2023","totalValueINR":"28628000","totalValueInUsd":"343965.4","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"8517614","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"NO.1 XIANYAO ROAD, XIANJU, ZHEJIANG,CHINASDNF China","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1699036200,"product":"MIFEPRISTONE IP","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"ZHEJIANG XIANJU PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"AQUATIC REMEDIES PVT LTD","customerCountry":"INDIA","quantity":"400.00","actualQuantity":"400","unit":"KGS","unitRateFc":"850","totalValueFC":"343793.7","currency":"USD","unitRateINR":"71570","date":"04-Nov-2023","totalValueINR":"28628000","totalValueInUsd":"343793.7","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"8617875","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"NO.1 XIANYAO ROAD, XIANJU, ZHEJIANG,CHINASDNF China","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701714600,"product":"MIFEPRISTONE IP","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"AQUATIC REMEDIES PVT LTD","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"850","totalValueFC":"42860.9","currency":"USD","unitRateINR":"71357.5","date":"05-Dec-2023","totalValueINR":"3567875","totalValueInUsd":"42860.9","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"9071031","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"NO.1 JUNYE ROAD XIANJU ZHEJIANG CHISDNF China","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701714600,"product":"MIFEPRISTONE IP","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"AQUATIC REMEDIES PVT LTD","customerCountry":"INDIA","quantity":"300.00","actualQuantity":"300","unit":"KGS","unitRateFc":"850","totalValueFC":"257624.8","currency":"USD","unitRateINR":"71485","date":"05-Dec-2023","totalValueINR":"21445500","totalValueInUsd":"257624.8","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"9078739","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"NO.1 JUNYE ROAD XIANJU ZHEJIANG CHISDNF China","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1704393000,"product":"MIFEPRISTONE","address":"C-3\/199, JANAK PURI,","city":"NEW DELHI","supplier":"ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"NAARI","customerCountry":"INDIA","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"1100","totalValueFC":"27876.6","currency":"USD","unitRateINR":"92675","date":"05-Jan-2024","totalValueINR":"2316875","totalValueInUsd":"27876.6","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"9538580","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"PHARMACEUTICAL CO.,LTD. NO.1JUNYE ROAD XIANJU ZHEJIANG, CHINA","customerAddress":"C-3\/199, JANAK PURI,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708885800,"product":"MIFEPRISTONE IP","address":"108, MARINE CHEMBERS, 43, NEW","city":"MUMBAI","supplier":"WUHAN JIULONG PHARMACEUTICAL CO.,LT","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"B.M. CHEMIE","customerCountry":"INDIA","quantity":"75.00","actualQuantity":"75","unit":"KGS","unitRateFc":"850","totalValueFC":"64461.6","currency":"USD","unitRateINR":"71315","date":"26-Feb-2024","totalValueINR":"5348625","totalValueInUsd":"64461.6","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"2305763","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"D. NO.77,OPTICS VALLEY SEVENTH ROAD,EAST LAKE HIGH- TECH DISTRICT,WUHAN 430206,HUBEI CHINA","customerAddress":"108, MARINE CHEMBERS, 43, NEW"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710527400,"product":"MIFEPRISTONE (FINE)","address":"C-3\/199, JANAK PURI,","city":"NEW DELHI","supplier":"FORMOSA LABORATORIES","supplierCountry":"TAIWAN","foreign_port":"TAIPEI","customer":"NAARI","customerCountry":"INDIA","quantity":"6.20","actualQuantity":"6.2","unit":"KGS","unitRateFc":"7500","totalValueFC":"46900","currency":"USD","unitRateINR":"628125","date":"16-Mar-2024","totalValueINR":"3894375","totalValueInUsd":"46900","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"2612136","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"TAIPEI","supplierAddress":"36 HOPING STREET, LOUCHU,TAOYUAN 33842SDNF TW","customerAddress":"C-3\/199, JANAK PURI,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711045800,"product":"MIFEPRISTONE","address":"C-3\/199, JANAK PURI,","city":"NEW DELHI","supplier":"ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"NAARI","customerCountry":"INDIA","quantity":"45.00","actualQuantity":"45","unit":"KGS","unitRateFc":"1080","totalValueFC":"49018","currency":"USD","unitRateINR":"90450","date":"22-Mar-2024","totalValueINR":"4070250","totalValueInUsd":"49018","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"2697974","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"PHARMACEUTICAL CO.,LTD. NO.1JUNYE ROAD XIANJU ZHEJIANG, CHINA","customerAddress":"C-3\/199, JANAK PURI,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714069800,"product":"MIFEPRISTONE IP","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"AQUATIC REMEDIES PVT LTD","customerCountry":"INDIA","quantity":"300.00","actualQuantity":"300","unit":"KGS","unitRateFc":"850","totalValueFC":"256962.5","currency":"USD","unitRateINR":"71527.5","date":"26-Apr-2024","totalValueINR":"21458250","totalValueInUsd":"256962.5","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"3216312","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"NO.1 JUNYE ROAD XIANJU ZHEJIANG CHISDNF China","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715106600,"product":"MIFEPRISTONE IP","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"ZHEJIANG XIANJU PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"AQUATIC REMEDIES PVT LTD","customerCountry":"INDIA","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"740","totalValueFC":"74928.5","currency":"USD","unitRateINR":"62456","date":"08-May-2024","totalValueINR":"6245600","totalValueInUsd":"74928.5","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"3383772","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"NO.1 XIANYAO ROAD, XIANJU, ZHEJIANG,CHINASDNF China","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715625000,"product":"MIFEPRISTONE IP","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"ZHEJIANG XIANJU PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"AQUATIC REMEDIES PVT LTD","customerCountry":"INDIA","quantity":"150.00","actualQuantity":"150","unit":"KGS","unitRateFc":"740","totalValueFC":"112392.7","currency":"USD","unitRateINR":"62456","date":"14-May-2024","totalValueINR":"9368400","totalValueInUsd":"112392.7","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"3474775","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"NO.1 XIANYAO ROAD, XIANJU, ZHEJIANG,CHINASDNF China","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1716316200,"product":"MIFEPRISTONE IP","address":"108, MARINE CHEMBERS, 43, NEW","city":"MUMBAI","supplier":"WUHAN JIULONG PHARMACEUTICAL CO., LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"B.M. CHEMIE","customerCountry":"INDIA","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"850","totalValueFC":"86015.5","currency":"USD","unitRateINR":"71697.5","date":"22-May-2024","totalValueINR":"7169750","totalValueInUsd":"86015.5","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"3600796","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.77, OPTICS VALLEY SEVENTH ROAD,EAST LAKE HIGH-TECH DISTRICT, WHUHAN 430206 HUBEI, , CHINA CHINA","customerAddress":"108, MARINE CHEMBERS, 43, NEW"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717612200,"product":"MIFEPRISTONE IP","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"ZHEJIANG XIANJU PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"AQUATIC REMEDIES PVT LTD","customerCountry":"INDIA","quantity":"150.00","actualQuantity":"150","unit":"KGS","unitRateFc":"740","totalValueFC":"112224.1","currency":"USD","unitRateINR":"62456","date":"06-Jun-2024","totalValueINR":"9368400","totalValueInUsd":"112224.1","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"3853819","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"NO.1 XIANYAO ROAD, XIANJU, ZHEJIANG,CHINASDNF China","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718303400,"product":"MIFEPRISTONE","address":"C-3\/199, JANAK PURI,","city":"NEW DELHI","supplier":"ZHEJIANG XIANJU PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"NAARI","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"1000","totalValueFC":"2019.7","currency":"USD","unitRateINR":"84300","date":"14-Jun-2024","totalValueINR":"168600","totalValueInUsd":"2019.7","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"3998277","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.1 XIANYAO ROADXIANJU,ZHEJIANG, CHINA","customerAddress":"C-3\/199, JANAK PURI,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720031400,"product":"MIFEPRISTONE IH\/IP","address":"VILL.GHOGADWAL (CHOKIWALA),","city":"","supplier":"SHANGHAI YOKACHEM TECHNOLOGY CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"ACME FORMULATION PVT LTD","customerCountry":"INDIA","quantity":"30.00","actualQuantity":"30","unit":"KGS","unitRateFc":"920","totalValueFC":"27834.1","currency":"USD","unitRateINR":"77556","date":"04-Jul-2024","totalValueINR":"2326680","totalValueInUsd":"27834.1","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"4323596","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"ROOM 607, 610 BUILDING 2 NO 1295 CHUANQIAO ROAD CHINA (SHANGHAI) Pudong\/Shanghai, , CHINA CHINA","customerAddress":"VILL.GHOGADWAL (CHOKIWALA),"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723487400,"product":"MIFEPRISTONE IP","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"AQUATIC REMEDIES PVT LTD","customerCountry":"INDIA","quantity":"200.00","actualQuantity":"200","unit":"KGS","unitRateFc":"735","totalValueFC":"148264.4","currency":"USD","unitRateINR":"62181","date":"13-Aug-2024","totalValueINR":"12436200","totalValueInUsd":"148264.4","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"5027688","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.1 JUNYE ROAD XIANJU ZHEJIANG CHISDNF CHINA","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724178600,"product":"MIFEPRISTONE","address":"C-3\/199, JANAK PURI,","city":"NEW DELHI","supplier":"ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"NAARI","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"1020","totalValueFC":"41272.5","currency":"USD","unitRateINR":"86547","date":"21-Aug-2024","totalValueINR":"3461880","totalValueInUsd":"41272.5","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"5163067","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.1 JUNYE ROADXIANJU ZHEJIANG, CHINA","customerAddress":"C-3\/199, JANAK PURI,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724697000,"product":"MIFEPRISTONE","address":"C-3\/199, JANAK PURI,","city":"NEW DELHI","supplier":"HUBEI GEDIAN HUMANWELL PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"EZHOU HUAHU","customer":"NAARI","customerCountry":"INDIA","quantity":"85.00","actualQuantity":"85","unit":"KGS","unitRateFc":"1000","totalValueFC":"85984.4","currency":"USD","unitRateINR":"84850","date":"27-Aug-2024","totalValueINR":"7212250","totalValueInUsd":"85984.4","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"5278507","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"EZHOU HUAHU","supplierAddress":"PHARMACEUTICAL CO., LTD GEDIANECONOMIC DEVELOPMENT DISTRICT,E-ZHOU (436070) HUBEI, CHINA","customerAddress":"C-3\/199, JANAK PURI,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725215400,"product":"MIFEPRISTONE IP","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"AQUATIC REMEDIES PVT LTD","customerCountry":"INDIA","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"745","totalValueFC":"377161.9","currency":"USD","unitRateINR":"63213.3","date":"02-Sep-2024","totalValueINR":"31606625","totalValueInUsd":"377161.9","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"5379492","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"NO.1 JUNYE ROAD XIANJU ZHEJIANG CHI NA SDNF CHINA CHINA","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725388200,"product":"MIFEPRISTONE IH\/IP","address":"VILL.GHOGADWAL (CHOKIWALA),","city":"","supplier":"SHANGHAI YOKACHEM TECHNOLOGY CO. LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"ACME FORMULATION PVT LTD","customerCountry":"INDIA","quantity":"30.00","actualQuantity":"30","unit":"KGS","unitRateFc":"920","totalValueFC":"27945.4","currency":"USD","unitRateINR":"78062","date":"04-Sep-2024","totalValueINR":"2341860","totalValueInUsd":"27945.4","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"5415245","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"ROOM 607, 610 BUILDING 2 NO 1295 CH UANQIAO ROAD CHINA (SHANGHAI) Pudon g\/Shanghai, , CHINA CHINA CHINA","customerAddress":"VILL.GHOGADWAL (CHOKIWALA),"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1728844200,"product":"MIFEPRISTONE","address":"C-3\/199, JANAK PURI,","city":"NEW DELHI","supplier":"HUBEI GEDIAN HUMANWELL PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"EZHOU HUAHU","customer":"NAARI","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"1000","totalValueFC":"40392","currency":"USD","unitRateINR":"84850","date":"14-Oct-2024","totalValueINR":"3394000","totalValueInUsd":"40392","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"6112062","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"EZHOU HUAHU","supplierAddress":"PHARMACEUTICAL CO., LTD GEDIAN ECONOMIC DEVELOPMENT DISTRICT, E-ZHOU (436070) HUBEI, CHINA","customerAddress":"C-3\/199, JANAK PURI,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1728844200,"product":"MIFEPRISTONE","address":"C-3\/199, JANAK PURI,","city":"NEW DELHI","supplier":"HUBEI GEDIAN HUMANWELL PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"EZHOU HUAHU","customer":"NAARI","customerCountry":"INDIA","quantity":"45.00","actualQuantity":"45","unit":"KGS","unitRateFc":"1000","totalValueFC":"45441","currency":"USD","unitRateINR":"84850","date":"14-Oct-2024","totalValueINR":"3818250","totalValueInUsd":"45441","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"6111023","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"EZHOU HUAHU","supplierAddress":"PHARMACEUTICAL CO., LTD GEDIAN ECONOMIC DEVELOPMENT DISTRICT, E-ZHOU (436070) HUBEI, CHINA","customerAddress":"C-3\/199, JANAK PURI,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729535400,"product":"MIFEPRISTONE IP(84371-65-3)","address":"CISONS COMPLEX,SHOPNO.77, 1ST FLOOR","city":"ROAD, EGMORE, CHENNAI, TAMIL NADU","supplier":"WUHAN JIULONG PHARMACEUTICAL ","supplierCountry":"CHINA","foreign_port":"EZHOU HUAHU","customer":"SYMBIO GENERRICS INDIA ","customerCountry":"INDIA","quantity":"200.00","actualQuantity":"200","unit":"KGS","unitRateFc":"735","totalValueFC":"148615.5","currency":"USD","unitRateINR":"62438.3","date":"22-Oct-2024","totalValueINR":"12487650","totalValueInUsd":"148615.5","indian_port":"Madras Air","hs_no":"29372900","bill_no":"6259489","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"EZHOU HUAHU","supplierAddress":"NO.77, OPTICS VALLEY SEVENTH ROAD, EAST LAKE HIGH-TECH DISTRICT, WUHAN, HUBEI CN","customerAddress":"CISONS COMPLEX,SHOPNO.77, 1ST FLOOR"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729621800,"product":"API MIFEPRISTONE P-2277 LOT 138014 BATCH NO PEMFRNF003. RE IMPORT DUE TO PARTICLE SIZE OF MATERIAL IS OUT OF SPECIFICATI","address":"ACME PLAZA, ANDHERI KURLA ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"HALO PHARMACEUTICAL INC","supplierCountry":"INDIA","foreign_port":"MONTREAL-DORAVAL APT","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"INDIA","quantity":"37.55","actualQuantity":"37.55","unit":"KGS","unitRateFc":"50","totalValueFC":"2671.8","currency":"USD","unitRateINR":"5978.7","date":"23-Oct-2024","totalValueINR":"224499.28","totalValueInUsd":"2671.8","indian_port":"Ahmedabad Air","hs_no":"29372900","bill_no":"6296979","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"MONTREAL-DORAVAL APT","supplierAddress":"17800 LAPOINTE STREET MIRABEL QC J7 J 0W8 SDNF CANADA","customerAddress":"ACME PLAZA, ANDHERI KURLA ROAD,"}]
    28-Oct-2023
    23-Oct-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Coating Systems & Additives

    read-more
    read-more

    Fillers, Diluents & Binders

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Granulation

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Topical

    read-more
    read-more

    Vegetarian Capsules

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search